Format

Send to

Choose Destination
See comment in PubMed Commons below
Mol Cell. 2007 Sep 7;27(5):717-30.

A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases.

Author information

1
Department of Pharmacology, New York University School of Medicine, New York, NY 10016, USA.

Abstract

Activating mutations in the tyrosine kinase domain of receptor tyrosine kinases (RTKs) cause cancer and skeletal disorders. Comparison of the crystal structures of unphosphorylated and phosphorylated wild-type FGFR2 kinase domains with those of seven unphosphorylated pathogenic mutants reveals an autoinhibitory "molecular brake" mediated by a triad of residues in the kinase hinge region of all FGFRs. Structural analysis shows that many other RTKs, including PDGFRs, VEGFRs, KIT, CSF1R, FLT3, TEK, and TIE, are also subject to regulation by this brake. Pathogenic mutations activate FGFRs and other RTKs by disengaging the brake either directly or indirectly.

PMID:
17803937
PMCID:
PMC2094128
DOI:
10.1016/j.molcel.2007.06.028
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center